Skip to main content

Research Repository

Advanced Search

All Outputs (2)

MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers (2014)
Journal Article
Jackson, B. L., Grabowska, A., & Ratan, H. L. (2014). MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers. BMC Cancer, 14(1), 1-10. https://doi.org/10.1186/1471-2407-14-930

Background This non-systematic review article aims to summarise the progress made in understanding the functional consequences of microRNA (miRNA) dysregulation in prostate cancer development, and the identification of potential miRNA targets as ser... Read More about MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy (2014)
Journal Article
Abbotts, R., Jewell, R., Nsengimana, J., Maloney, D. J., Simeonov, A., Seedhouse, C., …Madhusudan, S. (2014). Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy. Oncotarget, 5(10), 3273-3286. https://doi.org/10.18632/oncotarget.1926

Phosphatase and tensin homolog (PTEN) loss is associated with genomic instability. APE1 is a key player in DNA base excision repair (BER) and an emerging drug target in cancer. We have developed small molecule inhibitors against APE1 repair nuclease... Read More about Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.